Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea
· Delayed Price · Currency is KRW
88,500
-9,500 (-9.69%)
At close: Dec 5, 2025
Next Biomedical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 726,044 | 331,554 | - | - | - | - | |
| Enterprise Value | 706,868 | 316,300 | - | - | - | - | |
| Last Close Price | 88500.00 | 41000.00 | - | - | - | - | |
| PE Ratio | - | 115.95 | - | - | - | - | |
| PS Ratio | 48.71 | 34.74 | - | - | - | - | |
| PB Ratio | 15.70 | 7.34 | - | - | - | - | |
| P/TBV Ratio | 15.81 | 7.39 | - | - | - | - | |
| EV/Sales Ratio | 47.43 | 33.15 | - | - | - | - | |
| Debt / Equity Ratio | 0.18 | 0.24 | 0.70 | 0.56 | 6.25 | -0.37 | |
| Asset Turnover | 0.26 | 0.22 | 0.16 | 0.08 | 0.07 | 0.09 | |
| Inventory Turnover | 1.79 | 1.60 | 1.37 | 1.61 | 1.83 | 1.23 | |
| Quick Ratio | 3.29 | 3.68 | 1.35 | 1.38 | 1.70 | 0.18 | |
| Current Ratio | 3.64 | 3.95 | 1.57 | 1.59 | 1.82 | 0.24 | |
| Return on Equity (ROE) | -0.26% | 9.28% | -41.64% | -46.30% | - | - | |
| Return on Assets (ROA) | -1.49% | -5.05% | -10.57% | -10.03% | -13.55% | -12.52% | |
| Return on Capital (ROIC) | -1.58% | -5.31% | -11.14% | -10.68% | -64.38% | -4371.23% | |
| Return on Capital Employed (ROCE) | -2.90% | -7.60% | -28.70% | -27.30% | -26.10% | 35.50% | |
| Earnings Yield | -0.02% | 0.86% | - | - | - | - | |
| FCF Yield | -0.56% | -0.50% | - | - | - | - | |
| Buyback Yield / Dilution | -20.33% | -17.78% | -1.10% | -28.34% | -13.05% | -199.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.